TY - JOUR
T1 - 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced porphyria in genetically inbred mice
T2 - Partial antagonism and mechanistic studies
AU - Yao, C.
AU - Safe, S.
N1 - Funding Information:
This research was supported by the National Institutes of Health (ES-03843) and the Texas Agricultural Experiment Station.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1989/9/1
Y1 - 1989/9/1
N2 - 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (233 nmol/kg) causes a significant increase of hepatic uroporphyrin, heptacarboxyporphyrin, and total porphyrins in female C57BL/6 mice, ovariectomized C57BL/6 mice, male C57BL/10 mice, and male C57BL/6 mice 3 weeks after treatment. In contrast, 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) was inactive at a dose of 750 μmol/kg. Cotreatment of the mice with TCDD (233 mol/kg) plus MCDF (750 μmol/kg) resulted in partial antagonism of TCDD-induced hepatic porphyrin accumulation only in the female mice. Parallel studies in female C57BL/6 mice showed that the TCDD-induced porphyria was accompanied by the induction of hepatic microsomal aryl hydrocarbon hydroxylase (AHH) and ethoxyresorufin O-deethylase (EROD) activities and the depression of uroporphyrinogen decarboxylase (UROD). MCDF (750 μmol/kg) did not significantly affect these enzymes. In the cotreatment studies (MCDF plus TCDD), MCDF partially antagonized TCDD-induced hepatic porphyrin accumulation but did not affect the levels of hepatic AHH, EROD, or UROD. These results indicate that other factors, in addition to the induction of cytochrome P450-dependent monooxygenases and depressed UROD activity, are important in TCDD-induced porphyria in C57BL/6 female mice.
AB - 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (233 nmol/kg) causes a significant increase of hepatic uroporphyrin, heptacarboxyporphyrin, and total porphyrins in female C57BL/6 mice, ovariectomized C57BL/6 mice, male C57BL/10 mice, and male C57BL/6 mice 3 weeks after treatment. In contrast, 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) was inactive at a dose of 750 μmol/kg. Cotreatment of the mice with TCDD (233 mol/kg) plus MCDF (750 μmol/kg) resulted in partial antagonism of TCDD-induced hepatic porphyrin accumulation only in the female mice. Parallel studies in female C57BL/6 mice showed that the TCDD-induced porphyria was accompanied by the induction of hepatic microsomal aryl hydrocarbon hydroxylase (AHH) and ethoxyresorufin O-deethylase (EROD) activities and the depression of uroporphyrinogen decarboxylase (UROD). MCDF (750 μmol/kg) did not significantly affect these enzymes. In the cotreatment studies (MCDF plus TCDD), MCDF partially antagonized TCDD-induced hepatic porphyrin accumulation but did not affect the levels of hepatic AHH, EROD, or UROD. These results indicate that other factors, in addition to the induction of cytochrome P450-dependent monooxygenases and depressed UROD activity, are important in TCDD-induced porphyria in C57BL/6 female mice.
UR - http://www.scopus.com/inward/record.url?scp=0024444243&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024444243&partnerID=8YFLogxK
U2 - 10.1016/0041-008X(89)90307-4
DO - 10.1016/0041-008X(89)90307-4
M3 - Article
C2 - 2781554
AN - SCOPUS:0024444243
VL - 100
SP - 208
EP - 216
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
SN - 0041-008X
IS - 2
ER -